FI945085A0 - Yhdistelmä-neu-reseptoristimulaatiotekijä - Google Patents

Yhdistelmä-neu-reseptoristimulaatiotekijä

Info

Publication number
FI945085A0
FI945085A0 FI945085A FI945085A FI945085A0 FI 945085 A0 FI945085 A0 FI 945085A0 FI 945085 A FI945085 A FI 945085A FI 945085 A FI945085 A FI 945085A FI 945085 A0 FI945085 A0 FI 945085A0
Authority
FI
Finland
Prior art keywords
reseptoristimulaatiotekijä
neu
combination
Prior art date
Application number
FI945085A
Other languages
English (en)
Swedish (sv)
Other versions
FI945085A (fi
Inventor
Duanzhi Wen
Yosef Yarden
Elior Peles
Original Assignee
Amgen Inc
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Yeda Res & Dev filed Critical Amgen Inc
Publication of FI945085A0 publication Critical patent/FI945085A0/fi
Publication of FI945085A publication Critical patent/FI945085A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI945085A 1992-04-29 1994-10-28 Yhdistelmä-neu-reseptoristimulaatiotekijä FI945085A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87743192A 1992-04-29 1992-04-29
PCT/US1993/004128 WO1993022424A1 (en) 1992-04-29 1993-04-28 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR

Publications (2)

Publication Number Publication Date
FI945085A0 true FI945085A0 (fi) 1994-10-28
FI945085A FI945085A (fi) 1994-10-28

Family

ID=25369947

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945085A FI945085A (fi) 1992-04-29 1994-10-28 Yhdistelmä-neu-reseptoristimulaatiotekijä

Country Status (11)

Country Link
EP (1) EP0583050A3 (fi)
JP (1) JPH07506488A (fi)
KR (1) KR950701379A (fi)
CN (1) CN1080959A (fi)
AU (1) AU4228693A (fi)
CA (1) CA2134564A1 (fi)
FI (1) FI945085A (fi)
MX (1) MX9302475A (fi)
NO (1) NO944112L (fi)
WO (1) WO1993022424A1 (fi)
ZA (1) ZA933021B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7319019B1 (en) 1991-04-10 2008-01-15 Acorda Therapeutics, Inc. Glial mitogenic factors lacking an N-terminal signal sequence
US7135456B1 (en) 1991-04-10 2006-11-14 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US7094749B1 (en) 1991-04-10 2006-08-22 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7285531B1 (en) 1991-04-10 2007-10-23 Acorda Therapeutics, Inc. Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
US5834229A (en) * 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
US5367060A (en) * 1991-05-24 1994-11-22 Genentech, Inc. Structure, production and use of heregulin
AU7042994A (en) * 1993-05-21 1994-12-20 Amgen, Inc. Recombinant (neu) differentiation factors
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US5633161A (en) 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
JP4382879B2 (ja) 1996-07-12 2009-12-16 ジェネンテック・インコーポレーテッド ガンマ―ヘレグリン
US6136558A (en) * 1997-02-10 2000-10-24 Genentech, Inc. Heregulin variants
IL130827A0 (en) 1997-02-10 2001-01-28 Genentech Inc Heregulin variants
US20010023241A1 (en) 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
CA2455830C (en) 2001-07-31 2012-10-09 Wayne State University Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
DK1994141T3 (en) 2006-02-23 2018-02-12 Viacyte Inc COMPOSITIONS AND METHODS APPLICABLE FOR CULTIVATING DIFFERENTIBLE CELLS
ES2743204T3 (es) 2008-11-04 2020-02-18 Viacyte Inc Composiciones de suspensión de agregados de células madre y métodos para su diferenciación
AU2013248265B2 (en) 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO921040L (no) * 1991-03-17 1992-09-18 Yeda Res & Dev Stimulerende faktor for neu-reseptoren
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin

Also Published As

Publication number Publication date
KR950701379A (ko) 1995-03-23
NO944112D0 (no) 1994-10-28
JPH07506488A (ja) 1995-07-20
CA2134564A1 (en) 1993-11-11
WO1993022424A1 (en) 1993-11-11
ZA933021B (en) 1993-11-12
FI945085A (fi) 1994-10-28
AU4228693A (en) 1993-11-29
NO944112L (no) 1994-12-29
CN1080959A (zh) 1994-01-19
MX9302475A (es) 1994-05-31
EP0583050A3 (en) 1994-10-05
EP0583050A2 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
FI944885A (fi) Tölkin perusosa
DE59303358D1 (de) Quaterrylentetracarbonsäureimide
FI945085A0 (fi) Yhdistelmä-neu-reseptoristimulaatiotekijä
AT399443B (de) Sportschuh
DE59301902D1 (de) Kassenlade
ATA236892A (de) Rotornut
BR9301712A (pt) Aplainador
ATA227792A (de) Sportschuh
NO932967D0 (no) Di- henholdsvis triazindioner
DE59301762D1 (de) Chlorethylsulfonylbenzaldehyde
ITFE920013V0 (it) Endolancet a
BR7200437U (pt) Disposicao proporcionada a arandeia
ITRM920005V0 (it) Mutadina a perdere
DE59206388D1 (de) Kabeleckkanal
BR9200231A (pt) Agrupador
BR9201723A (pt) Filatorio
BR7200240U (pt) Vari-watt
BR7200318U (pt) Cabide sanfonado
BR7200879U (pt) Cocho saleiro biazi
BR7201352U (pt) Luninaria
BR7201859U (pt) Cambao
BR7202026U (pt) Aero-mala
BR7200188U (pt) Hidro-cinzeiro
BR9200295A (pt) Aurissima
BR9200296A (pt) Varre-lava

Legal Events

Date Code Title Description
FD Application lapsed